View of A Novel Multi-analyte Serum Panel Combining CA-125, HE4, microRNA-200a, and Interleukin-6 for the Preclinical Detection of High-Grade Serous Ovarian Carcinoma in Women with Pathogenic *BRCA1/2* Variants

Return to Article Details A Novel Multi-analyte Serum Panel Combining CA-125, HE4, microRNA-200a, and Interleukin-6 for the Preclinical Detection of High-Grade Serous Ovarian Carcinoma in Women with Pathogenic *BRCA1/2* Variants Download Download PDF